Collagenase Compositions for Orthodontic Procedures Patent Application
Summary
The USPTO has published a patent application detailing compositions comprising collagenase and their uses in orthodontic procedures. The application, filed by inventors from Israel, describes potential uses for recombinant collagenase and modified forms thereof in dental treatments.
What changed
This document is a published patent application (US20260083641A1) from the USPTO concerning compositions containing collagenase for use in orthodontic procedures. The application specifically mentions recombinant collagenase and modified forms, including those with amino acid truncations or substitutions, as potential therapeutic agents for dental applications.
As this is a patent application, it does not impose direct regulatory obligations or compliance deadlines on regulated entities. However, it signals potential future developments in the pharmaceutical and medical device sectors related to dental treatments. Companies involved in drug development, medical devices, or orthodontic products may wish to monitor the progress of this patent application and related technologies for competitive intelligence and potential licensing opportunities.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITIONS COMPRISING COLLAGENASE AND USES THEREOF IN ORTHODONTIC PROCEDURES
Application US20260083641A1 Kind: A1 Mar 26, 2026
Inventors
Maayan GAL, Orel COHEN, Diva LUGASSY, Itzhak BINDERMAN, Evgeny WEINBERG
Abstract
Provided herein compositions including collagenase, and uses thereof in orthodontic procedures, wherein the compositions may include recombinant collagenase and/or modified forms of recombinant collagenase having amino acid(s) truncation or substitutions.
CPC Classifications
A61K 6/50 A61K 6/69 C12Y 304/24003
Filing Date
2025-12-01
Application No.
19404309
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.